Ripon College working with Eli Lilly to screen molecules for potential pharmaceutical use
Ripon College now is affiliated with the Open Innovation Drug Discovery Program at Eli Lilly. Through this program, students and faculty will use the technology at Eli Lilly to virtually screen molecules for their potential to be pharmaceuticals. After virtual screening, students and faculty will send molecules prepared at Ripon College to Eli Lilly for actual biological testing.
This program allows students and faculty to use their research to directly participate in the discovery of new pharmaceuticals. For example, several students in Assistant Professor of Chemistry Patrick Willoughby’s research lab have synthesized many completely new molecules. These molecules now can be assessed for their viability to treat disease and other ailments.
“I am excited to see student research at Ripon College directly contribute to the discovery of new drugs,” Willoughby says. “This undoubtedly will enhance their understanding of modern medicine and positively affect the prospect of them pursuing a career in health sciences.”
Related Posts
Brian Bockelman awarded residential fellowship at Harvard-owned research center
Brian Bockelman, professor of history and interim director of strategic initiatives, has been awarded a residential fellowship at Dumbarton Oaks, a Harvard-owned estate, museum and […]
Soren Hauge interviewed about recent interest rate hikes
Soren Hauge, professor of economics, spoke Thursday, June 16, for Spectrum News 1, a statewide news and information network. He discussed key interest rate hikes […]
Travis Nygard has chapter in newly published book
Associate Professor of Art Travis Nygard has a chapter in the new book A Companion to American Agricultural History, edited by Douglas Hurt and released […]
Erin K. Bryan wins honorable mention in national competition
Assistant Professor of Music Erin K. Bryan has won an honorable mention as a finalist in the 2022 The American Prize in Vocal Performance — […]
